September 11, 2024 12:26 GMT
Haleon (HLNLN; Baa1 Pos/BBB+) Secondary (split from GSK in '22)
CONSUMER STAPLES
€4Y priced -2bps through yet secondary is very weak (+7-8bps) and adding to a 5bp move from Monday on mandate announcement. It's giving +13bps for 1.5yr extension and into a low cash px (€93).
£28/38s were +3-5bps today and adding to a +4-8bp move from this week. Reckitt lines look mute (€ unch to +3, £ unch to +2) - we take that as longs are happy to sit through more NEC headlines.
73 words